121 related articles for article (PubMed ID: 37879219)
21.
Liu X; Guo R; Xu Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
[No Abstract] [Full Text] [Related]
22. The protective role of DMBT1 in cervical squamous cell carcinoma.
Zhang CX
Kaohsiung J Med Sci; 2019 Dec; 35(12):739-749. PubMed ID: 31400059
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
[TBL] [Abstract][Full Text] [Related]
24. LncRNA ANCR downregulates hypoxia‑inducible factor 1α and inhibits the growth of HPV‑negative cervical squamous cell carcinoma under hypoxic conditions.
Ta W; Zhang Y; Zhang S; Sun P
Mol Med Rep; 2020 Jan; 21(1):413-419. PubMed ID: 31746351
[TBL] [Abstract][Full Text] [Related]
25. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
Chen P; Wang Y; Li J; Bo X; Wang J; Nan L; Wang C; Ba Q; Liu H; Wang H
Clin Transl Med; 2021 Jun; 11(6):e462. PubMed ID: 34185421
[TBL] [Abstract][Full Text] [Related]
26. lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma.
Liu H; Zhu C; Xu Z; Wang J; Qian L; Zhou Q; Shen Z; Zhao W; Xiao W; Chen L; Zhou Y
Cancer Sci; 2020 Nov; 111(11):4129-4141. PubMed ID: 32920922
[TBL] [Abstract][Full Text] [Related]
27. LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells.
Zhang Y; Na R; Wang X
BMC Cancer; 2019 Nov; 19(1):1052. PubMed ID: 31694597
[TBL] [Abstract][Full Text] [Related]
28. Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
Zuo Y; Xiao H; Lv D; Huang M; Wang L; Liu J; Zhang K; Shen J; Wang Z; Wu Q; Xu Y
J Med Virol; 2023 Apr; 95(4):e28717. PubMed ID: 37184049
[TBL] [Abstract][Full Text] [Related]
29. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
30. Screening of biomarkers in cervical squamous cell carcinomas via gene expression profiling.
Chen B; Li C; Zhang L; Lv J; Tong Y
Mol Med Rep; 2015 Nov; 12(5):6985-9. PubMed ID: 26398134
[TBL] [Abstract][Full Text] [Related]
31. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.
Nagura M; Matsumura N; Baba T; Murakami R; Kharma B; Hamanishi J; Yamaguchi K; Abiko K; Koshiyama M; Mandai M; Murata T; Murphy SK; Konishi I
Gynecol Oncol; 2015 Jan; 136(1):104-11. PubMed ID: 25434636
[TBL] [Abstract][Full Text] [Related]
32. Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer.
Zhang T; Zhuang L; Muaibati M; Wang D; Abasi A; Tong Q; Ma D; Jin L; Huang X
EBioMedicine; 2023 Jun; 92():104612. PubMed ID: 37224771
[TBL] [Abstract][Full Text] [Related]
33. Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3
Qu X; Wang Y; Jiang Q; Ren T; Guo C; Hua K; Qiu J
Cancer Commun (Lond); 2023 Nov; 43(11):1207-1228. PubMed ID: 37794698
[TBL] [Abstract][Full Text] [Related]
34. LncRNA SRA1 is down-regulated in HPV-negative cervical squamous cell carcinoma and regulates cancer cell behaviors.
Liu Y; Li M; Yu H; Piao H
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31371629
[TBL] [Abstract][Full Text] [Related]
35. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
Yan C; Ma Y; Li J; Chen X; Ma J
Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
[TBL] [Abstract][Full Text] [Related]
36. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
37. T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.
Bauer C; Abdul Pari AA; Umansky V; Utikal J; Boukamp P; Augustin HG; Goerdt S; Géraud C; Felcht M
Cancer Immunol Immunother; 2018 Jul; 67(7):1147-1157. PubMed ID: 29799076
[TBL] [Abstract][Full Text] [Related]
38. LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
Lan L; Liang Z; Zhao Y; Mo Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31985002
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
Ju W; Luo X; Zhang N
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
